Saturday Edition
Stay updated with Archyde – your source for breaking news, global headlines, economy, entertainment, health, technology, and sports. Fresh stories daily.
In a landmark randomized trial published this week in Nature Medicine, researchers found that subcutaneous injections of abatacept—a T-cell costimulation blocker—were significantly more effective than oral hydroxychloroquine in preventing progression ... Read More
Continuous Coverage
There is a specific kind of tension that settles over the National League West when the Colorado Rockies…
Hollywood’s weather is a masterclass in fiction—where blizzards defy physics, hurricanes materialize overnight, and meteorologists exist only to…
Virginia is experiencing a significant surge in tick-borne illnesses this May, resulting in a measurable increase in emergency…
DC and Marvel are pivoting away from long-term creator runs, opting for shorter, high-impact arcs to align with…
The 2026 NFL Thanksgiving schedule leak reveals a high-stakes slate featuring the Detroit Lions, Dallas Cowboys, and Kansas…
Scientists have identified a rare clathrate crystal forged during the 1945 Trinity nuclear test. This “impossible” structure, which…
Global Affairs
President Donald Trump and Chinese President Xi Jinping concluded a high-stakes summit this Thursday, May 14, 2026, focusing…
Markets And Money
Poland is launching a new state-backed electric vehicle (EV) project, pivoting from the previous Izera initiative toward a…
Digital Culture
In May 2026, the mid-range smartphone market has reached a critical inflection point where hardware-level stabilization is no…
Science And Wellbeing
A multi-country hantavirus cluster linked to cruise ship travel has prompted global health alerts, with confirmed cases in…
Screen And Sound
The BBC is reviving the acclaimed audio series Short Cuts through a strategic co-production partnership with Canada’s CBC…
Fixtures And Form
Chelsea’s managerial search has narrowed to two front-runners—Xabi Alonso and Andoni Iraola—as the club accelerates talks ahead of…
